Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

c-Myb trans-activates the human DNA topoisomerase IIalpha gene promoter.

Brandt TL, Fraser DJ, Leal S, Halandras PM, Kroll AR, Kroll DJ.

J Biol Chem. 1997 Mar 7;272(10):6278-84.

2.
3.

The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells.

Singh R, Winn LM.

Mutat Res. 2008 Oct 14;645(1-2):33-8. doi: 10.1016/j.mrfmmm.2008.08.007. Epub 2008 Aug 20.

PMID:
18778717
4.
5.

Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cells.

Ratajczak MZ, Perrotti D, Melotti P, Powzaniuk M, Calabretta B, Onodera K, Kregenow DA, Machalinski B, Gewirtz AM.

Blood. 1998 Mar 15;91(6):1934-46.

6.

Sp1 mediates cell proliferation-dependent regulation of rat DNA topoisomerase IIalpha gene promoter.

Yoon JH, Kim JK, Rha GB, Oh M, Park SH, Seong RH, Hong SH, Park SD.

Biochem J. 1999 Dec 1;344 Pt 2:367-74.

7.

Mechanism of c-myc regulation by c-Myb in different cell lineages.

Cogswell JP, Cogswell PC, Kuehl WM, Cuddihy AM, Bender TM, Engelke U, Marcu KB, Ting JP.

Mol Cell Biol. 1993 May;13(5):2858-69.

8.

C/EBPepsilon directly interacts with the DNA binding domain of c-myb and cooperatively activates transcription of myeloid promoters.

Verbeek W, Gombart AF, Chumakov AM, Müller C, Friedman AD, Koeffler HP.

Blood. 1999 May 15;93(10):3327-37.

9.
10.

ATF is important to late S phase-dependent regulation of DNA topoisomerase IIalpha gene expression in HeLa cells.

Son MY, Kim TJ, Kweon KI, Park JI, Park C, Lee YC, No Z, Ahn JW, Yoon WH, Park SK, Lim K, Hwang BD.

Cancer Lett. 2002 Oct 8;184(1):81-8.

PMID:
12104051
11.

Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products.

Nakagoshi H, Kanei-Ishii C, Sawazaki T, Mizuguchi G, Ishii S.

Oncogene. 1992 Jun;7(6):1233-40.

PMID:
1594249
12.

Human A-myb gene encodes a transcriptional activator containing the negative regulatory domains.

Takahashi T, Nakagoshi H, Sarai A, Nomura N, Yamamoto T, Ishii S.

FEBS Lett. 1995 Jan 16;358(1):89-96.

13.

Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor.

Wang Q, Zambetti GP, Suttle DP.

Mol Cell Biol. 1997 Jan;17(1):389-97.

14.

Regulation of the human topoisomerase IIalpha gene promoter in confluence-arrested cells.

Isaacs RJ, Harris AL, Hickson ID.

J Biol Chem. 1996 Jul 12;271(28):16741-7.

15.

Transcription regulation by murine B-myb is distinct from that by c-myb.

Watson RJ, Robinson C, Lam EW.

Nucleic Acids Res. 1993 Jan 25;21(2):267-72.

17.

Transactivation of an intronic hematopoietic-specific enhancer of the human Wilms' tumor 1 gene by GATA-1 and c-Myb.

Zhang X, Xing G, Fraizer GC, Saunders GF.

J Biol Chem. 1997 Nov 14;272(46):29272-80.

18.

c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-Myb.

Kanei-Ishii C, Yasukawa T, Morimoto RI, Ishii S.

J Biol Chem. 1994 Jun 3;269(22):15768-75.

19.

Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.

Nürnberg W, Artuc M, Nawrath M, Lovric J, Stüting S, Moelling K, Czarnetzki BM, Schadendorf D.

Cancer Res. 1995 Oct 1;55(19):4432-7.

20.

TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.

Foos G, Natour S, Klempnauer KH.

Oncogene. 1993 Jul;8(7):1775-82.

PMID:
8510924
Items per page

Supplemental Content

Write to the Help Desk